Nascent Biotech Inc.
NBIO
Revenue
0.00
▼-1.00M▼-100.00%
12 Months ChangeAssets
227.39k
▼-324.73k▼-58.81%
3 Months ChangeLiabilities
741.93k
▼-66.86k▼-8.27%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-14
Form 10-Q
ID: 0001477932-24-004823
2024-02-14
Form 10-Q
ID: 0001477932-24-000722
2023-12-19
Form 8-K
ID: 0001477932-23-009228
2023-11-09
Form 10-Q
ID: 0001477932-23-008227
2023-09-06
Form 8-K
ID: 0001477932-23-006645
2023-08-18
Form 10-Q
ID: 0001477932-23-006278
2023-07-14
Form 8-K
ID: 0001477932-23-005292
2023-05-30
Form 8-K
ID: 0001477932-23-004024
2023-05-09
Form 8-K
ID: 0001477932-23-003188
2023-02-14
Form 10-Q
ID: 0001477932-23-000947